Recent Posts on This Topic | See All >
Experimental cancer drug tested in Scottsdale shows promiseTags: cancer research, scottdale health care, tgen
[Source: Ken Alltucker, The Aizona republic] - An experimental cancer drug tested at Scottsdale Healthcare appears to shrink tumors in some skin cancer patients without significant side effects, local researchers said.
The experimental drug GDC-0449 showed promise in a phase-one trial, but it must be tested in more advanced trials with a larger group of patients to gauge the drug's effectiveness, they added.
It was used to test patients with advanced basal cell carcinoma, a rare type of skin cancer.
For more information: Experimental cancer drug tested in Scottsdale shows promise
Now available: “Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is now available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” An overview by Walter Plosila, Ph.D., Battelle senior advisor, is also available. The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade.